RESUMO
The synthesis, X-ray crystal structures, and photochemical behavior of a series of methyl- and ethylene-bridge-substituted trans-4-(N-(4-cyanophenyl)amino)stilbenes (3-8) are reported and compared to those of the parent compound 1CN. Aminostilbene 1CN displays dual fluorescence in polar solvents due to planar and twisted intramolecular charge-transfer (PICT and TICT) states. Alkyl substitution on the stilbene group of 1CN significantly perturbs its photochemistry, including fluorescence, trans --> cis photoisomerization, and TICT state formation. The alkyl substituent effect can be dissected into electronic and steric influences, and both are position dependent, which is vinyl alpha-carbon > vinyl beta-carbon > phenyl o-carbon. The main outcome of the alkyl substituent effect is to lower the barrier for the singlet-state photoisomerization. As a result, the quantum yield for photoisomerization is increased, and that for fluorescence is reduced. The corresponding quantum yield for TICT state formation in polar solvents is reduced only when significant ground-state twisting (a steric influence) is present. The alkyl substitution exerts little or no effect on the rate of intersystem crossing.
RESUMO
Variety of N-(4-phenyl-3-(2',3',4'(un)substituted phenyl)thiazol-2(3H)-ylidene)-2,4(un)substituted acridin-9-amine (4a-o) and 1-[(2,4-(un)substituted acridin-9-yl)-3-(4-phenyl-3-(2',3',4'(un)substituted phenyl)thiazol-2(3H)-ylidene)]isothiourea (5a-h) derivatives have been synthesized by condensation of 4-phenyl-3-(2',3',4'(un)substituted phenyl)thiazol-2(3H)-imine (3a-g) with 9-chloro-2,4-(un)substituted acridine (1a-c) and 9-isothiocyanato-2,4-(un)substituted acridine (2a-d), respectively. All these compounds were characterized by correct 1H NMR, FT-IR, MS and elemental analyses. These compounds were screened for anti-inflammatory, analgesic and kinase (CDK1, CDK5 and GSK3) inhibition activities. Some compounds exhibited good anti-inflammatory (25-32%) and potent analgesic (50-75%) activities, at 50 mg/kg p.o. A compound, 4o (R1 = H, R2 = OCH3, R3 = CH3, R4 = CH3, R5 = H) exhibited moderate CDK1 (IC50 = 8.5 microM) inhibition activity.
Assuntos
Acridinas/síntese química , Analgésicos/síntese química , Anti-Inflamatórios não Esteroides/síntese química , Inibidores Enzimáticos/síntese química , Tiazóis/síntese química , Acridinas/química , Acridinas/farmacologia , Analgésicos/química , Analgésicos/farmacologia , Animais , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/farmacologia , Benzoquinonas/toxicidade , Encéfalo/metabolismo , Proteína Quinase CDC2/metabolismo , Carragenina/toxicidade , Quinase 5 Dependente de Ciclina , Quinases Ciclina-Dependentes/metabolismo , Edema/induzido quimicamente , Edema/prevenção & controle , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Feminino , Quinase 3 da Glicogênio Sintase/metabolismo , Camundongos , Medição da Dor/efeitos dos fármacos , Ratos , Suínos , Tiazóis/química , Tiazóis/farmacologiaRESUMO
Various 2-thiopyrimidine derivatives have been synthesized by an efficient, one-pot reaction of functionalized amines with either 4-isothiocyanato-4-methyl-2-pentanone or 3-isothiocyanatobutanal. All the synthesized compounds were fully characterized by elemental analysis (CHN), FT-IR, (1)H NMR, and mass spectral data. One of the compounds, 7,7,8a-trimethyl-hexahydro-thiazolo[3,2-c]pyrimidine-5-thione (17) showed good anti-inflammatory (37.4% at 100 mg/kg p.o.) and analgesic activity (75% at 100 mg/kg p.o.). 7-(1-Mercapto-3,3,4a-trimethyl-4,4a,5,9b-tetrahydro-3H-pyrido[4,3-b]indol-7-yl)-3,3,4a-trimethyl-3,4,4a,5-tetrahydro-benzo[4,5]imidazo[1,2-c]pyrimidine-1-thiol (3) showed moderate activity against CDK-1 (IC(50)=5 microM). The other compounds showed moderate anti-inflammatory (5-20%), analgesic (25-75%) and protein kinase (CDK-5, GSK-3) inhibitory activities (IC(50)> 10 microM).